ArticleJournal of the National Cancer Institute2026

The impact of eligibility criteria on Kirsten rat sarcoma G12C inhibitor trials in patients with non-small cell lung cancer.

Margaux Wooster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.